Sean A. McCarthy, CEO, Director at CytomX Therapeutics, holds 727.41K shares in CytomX Therapeutics (Ticker: CTMX). Most recently, Sean A. McCarthy Bought $109,768 shares of CytomX Therapeutics on Mar 28, 2024 for an estimated value of 172.34K.
What is the percentage of profitable transactions made by Sean A. McCarthy?
The percentage of profitable transactions made by Sean A. McCarthy is 14%.
What is the average return per transaction made by Sean A. McCarthy?
The average return per transaction made by Sean A. McCarthy is -30.30%.
What stocks does Sean A. McCarthy hold?
Sean A. McCarthy holds: CTMX stocks.
What was Sean A. McCarthy’s latest transaction?
Sean A. McCarthy latest transaction was an Informative Buy of $172.34K.
What was Sean A. McCarthy's most profitable transaction?
Sean A. McCarthy’s most profitable transaction was an Informative Buy of CTMX stock on June 27, 2017. The return on the trade was 59.30%.
What is Sean A. McCarthy's role in CytomX Therapeutics?
Sean A. McCarthy's role in CytomX Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.